The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2015

Filed:

Oct. 20, 2008
Applicants:

Wajahat Mehal, Guilford, CT (US);

Avlin Imaeda, Guilford, CT (US);

Inventors:

Wajahat Mehal, Guilford, CT (US);

Avlin Imaeda, Guilford, CT (US);

Assignee:

YALE UNIVERSITY, New Haven, CT (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 31/60 (2006.01); A61K 45/06 (2006.01); A61K 9/02 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0019 (2013.01); A61K 31/198 (2013.01); A61K 31/60 (2013.01); A61K 45/06 (2013.01); A61K 9/0014 (2013.01); A61K 9/0031 (2013.01); A61K 9/0046 (2013.01); A61K 9/0048 (2013.01); A61K 9/0073 (2013.01); A61K 9/02 (2013.01);
Abstract

The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when coadministered in effective amounts with a drug or other bioactive agent which typically (in the absence of the salicylate compound) produces significant hepatotoxicity as a secondary indication, will substantially reduce or even eliminate such hepatotoxicity. Favorable therapeutic intervention results from the use of the present invention having the effect of reducing hepatotoxicity associated with the administration of certain drugs and other bioactive agents and in certain instances of allowing the administration of higher doses of a compound which, without the coadministration, would produce hepatotoxicity which limits or even negates the therapeutic value of the compound.


Find Patent Forward Citations

Loading…